About Goldschleger Eye Research Institute, Sheba Medical Center,
המרכז הרפואי ע"ש חיים שיבא – תל השומר הוא בית החולים הגדול ביותר בישראל, הממוקם באזור תל השומר השייך לרמת גן. בית החולים קרוי על שם חיים שיבא. בית החולים זכה במקום התשיעי בדירוג בתי החולים הטובים ביותר בעולם המפותח של מגזין ניוזוויק בשיתוף חברת Statista לשנת 2020.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Goldschleger Eye Research Institute, Sheba Medical Center,
During the past decade, Goldschleger Eye Research Institute, Sheba Medical Center, conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Goldschleger Eye Research Institute, Sheba Medical Center,"
#1 collaborator was "Universitaire Ziekenhuizen KU Leuven" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Goldschleger Eye Research Institute, Sheba Medical Center,
According to Clinical.Site data, the most researched conditions in "Goldschleger Eye Research Institute, Sheba Medical Center," are
"Blepharoptosis" (1 trials), "Corneal Transplantation" (1 trials), "Healthy Volunteers" (1 trials), "Neovascular Age Related Macular Degeneration" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Goldschleger Eye Research Institute, Sheba Medical Center," in a lesser frequency.
Clinical Trials Intervention Types at Goldschleger Eye Research Institute, Sheba Medical Center,
Most popular intervention types in "Goldschleger Eye Research Institute, Sheba Medical Center," are "Procedure" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alga Dunaliella Bardawil powder" (1 trials), "Bevacizumab" (1 trials), "IOP measurement" (1 trials), "Injection of Saline + Lidocaine/Adrenaline" (1 trials) and "Lidocaine/Adrenaline only" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Goldschleger Eye Research Institute, Sheba Medical Center,
The vast majority of trials in "Goldschleger Eye Research Institute, Sheba Medical Center," are
7 trials for "All" genders.
Clinical Trials Status at Goldschleger Eye Research Institute, Sheba Medical Center,
Currently, there are NaN active trials in "Goldschleger Eye Research Institute, Sheba Medical Center,".
1 are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Goldschleger Eye Research Institute, Sheba Medical Center,,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Goldschleger Eye Research Institute, Sheba Medical Center,, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".